the impact of allosct versus blood transfusion & iron chelation on the qol of patients with tdt
Published 1 month ago • 118 plays • Length 3:49Download video MP4
Download video MP3
Similar videos
-
1:30
the impact of anemia and transfusion dependence on patient qol in myelofibrosis
-
2:14
addressing the high rate of disease relapse following allosct in patients with aml
-
8:57
outcomes of sct in t-all and t-lbl
-
1:24
conventional approaches for all targeted therapies in allo-hsct
-
5:37
red blood cell exchange through your patients’ eyes
-
2:07
the clearance of driver mutations following allosct impacts myelofibrosis disease outcomes
-
2:26
assessing the impact of momelotinib on transfusion burden in mf: analysis of simplify-1 & momentum
-
2:00
the role of fedratinib in 2024 and beyond
-
51:37
side effects to iv iron by joseph thomas | sabm
-
26:21
erythrocytes, hemoglobin & the iron cycle
-
24:27
haematology - blood transfusions
-
3:46
the impact of cytogenetic risk on outcomes of haploidentical transplantation in r/r aml
-
5:17
the effects of blood transfusions on iron accumulation
-
1:48
an analysis of transfusion-related cost offsets & time burden in pts with mf in the momentum trial
-
2:57
the importance of analyzing cytogenetic risk in patients with aml undergoing haploidentical sct
-
1:58
transfusion-independence associated with os in simplify-1 and simplfy-2
-
2:08
juntendo research video -dr. araki, the department of blood transfusion and stem cell regulation-
-
1:34
are thrombotic risk and progression in et predictable?
-
1:19
telomerase inhibition as a novel targeted therapy for myelofibrosis
-
1:59
the role of upfront double auto-sct in high-risk myeloma
-
1:30
targeting the complement cascade in autoimmune hemolytic anemias
-
2:41
cell avidity as a predictor of t-cell efficacy